• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Long COVID

Also knwon as post-COVID conditions, long COVID is a complication following infection with the virus that causes COVID-19. 

3D rendering of SARS-CoV-2 virus particles
Research

COVID antibodies shut down variants, earn $35M BARDA bucks

To “box in” SARS-CoV-2, researchers made multispecific antibodies that neutralize COVID strains and prevent the virus from evolving escape methods.
Darren Incorvaia Oct 9, 2024 2:00pm
Graphic image of a body shaded in black with drawn clouds around their head Dark blue background

GeNeuro's long COVID trial fails, triggering layoffs

Jun 28, 2024 5:34am
Graphic image of a body shaded in black with drawn clouds around their head Dark blue background

NIH to invest another $515M over 4 years for long COVID research

Feb 15, 2024 10:57am
Long COVID

Immune dysfunction link to long COVID opens door to therapies

Jan 19, 2024 6:00am
neon closed sign in window

Flagship-founded Axcella folds

Dec 5, 2023 10:36am
long COVID

Tonix redirects long COVID med toward fatigue after fail in pain

Sep 5, 2023 9:52am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings